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Abstract: The understanding of the pathogenic mechanisms and the clinicopathological forms caused
by currently circulating African swine fever virus (ASFV) isolates is incomplete. So far, most of the
studies have been focused on isolates classified within genotypes I and II, the only genotypes that
have circulated outside of Africa. However, less is known about the clinical presentations and lesions
induced by isolates belonging to the other twenty-two genotypes. Therefore, the early clinicopatholog-
ical identification of disease outbreaks caused by isolates belonging to, as yet, not well-characterised
ASFV genotypes may be compromised, which might cause a delay in the implementation of control
measures to halt the virus spread. To improve the pathological characterisation of disease caused
by diverse isolates, we have refined the macroscopic and histopathological evaluation protocols to
standardise the scoring of lesions. Domestic pigs were inoculated intranasally with different doses
(high, medium and low) of ASFV isolate Ken05/Tk1 (genotype X). To complement previous studies,
the distribution and severity of macroscopic and histopathological lesions, along with the amount
and distribution of viral antigen in tissues, were characterised by applying the new scoring protocols.
The intranasal inoculation of domestic pigs with high doses of the Ken05/Tk1 isolate induced acute
forms of ASF in most of the animals. Inoculation with medium doses mainly induced acute forms
of disease. A less severe but longer clinical course, typical of subacute forms, characterised by
the presence of more widespread and severe haemorrhages and oedema, was observed in one pig
inoculated with the medium dose. The severity of vascular lesions (haemorrhages and oedema)
induced by high and medium doses was not associated with the amount of virus antigen detected in
tissues, therefore these might be attributed to indirect mechanisms not evaluated in the present study.
The absence of clinical signs, lesions and detectable levels of virus genome or antigen in blood from
the animals inoculated with the lowest dose ruled out the existence of possible asymptomatic carriers
or persistently infected pigs, at least for the 21 days period of the study. The results corroborate the
moderate virulence of the Ken05/Tk1 isolate, as well as its capacity to induce both the acute and,
occasionally, subacute forms of ASF when high and medium doses were administered intranasally.
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1. Introduction
African swine fever (ASF) is a devastating viral haemorrhagic disease caused by
a complex DNA arbovirus, the ASF virus (ASFV), the only member of the Asfarviridae
family [1] that affects all members of the family Suidae [2]. ASF was first described in
Kenya [3] where the virus spread from asymptomatic infected warthogs (Phacochoerus
aethiopicus) to domestic pigs (Sus scrofa), causing high mortality rates in the pigs. Eurasian
wild boar and feral pigs (Sus scrofa) succumb to ASFV and can transmit the virus to domestic
pigs. No commercial vaccines against ASF are available. In 2007, ASF was present only in
Africa and the island of Sardinia, Italy. However, the epidemiological situation changed
dramatically with the incursion of ASFV genotype II into Georgia in 2007. From there,
ASFV spread to the Trans Caucasus countries and the Russian Federation. In 2014, the
virus entered in the European Union (EU), affecting the Baltic countries and continuing
its expansion into Eastern Europe, with a long-distance introduction into Belgium in
September 2018 [4]. In September 2020, Germany became the latest EU country to be
affected [5]. Furthermore, in August 2018 the genotype II virus reached China [6], where
almost half of the global pig population resides, spreading out of control to several countries
in Asia and threatening the Australian continent [7]. Twenty-four distinct genotypes of
ASFV have been described up to now [8,9], although only a few genome sequences have
been published, of which only some have sufficient data available to enable in-depth genetic
investigations [1,10]. In addition, studies to characterise the virulence and pathogenic
mechanisms of isolates belonging to different genotypes have been mainly focused on
viruses classified within genotype I [11–20] and genotype II [21–26], the only genotypes
that have circulated outside of Africa, to date.
There are gaps in the basic knowledge of the biological and molecular features of the
currently circulating ASFV isolates in Africa and Europe [27]. This knowledge is necessary
to understand the pathogenic mechanisms and to characterise the clinicopathological
forms caused by new ASFV isolates with potentially devastating consequences for the
pork industry, exemplified by the case of the transcontinental spread of genotype II ASFV.
Some studies have reported very low genetic variability in the circulating genotype II
ASFV isolates in Europe and Asia since the incursion of the virus into Georgia in 2007 [10].
However, other studies have found genetic variations among genotype I ASFV isolates
historically circulating in Western Africa, Europe and America, and also in genotype II
ASFV isolates circulating in Europe and Eastern and Southern Africa [9,28–30]. It is unclear
if the genetic variability of ASFV isolates classified within the different genotypes may
influence the pathogenicity. For instance, previous experimental comparative infections
in domestic pigs with the ASFV isolate Ken05/Tk1 (genotype X), used in the present
study, and an isolate with a relatively similar genome sequence belonging to genotype IX
(Ken06.Bus), revealed a marked difference in virulence [31].
Traditionally, ASFV isolates have been classified as highly virulent, responsible for
peracute and acute forms of disease with case fatality up to 100%, moderately virulent,
resulting in acute and subacute forms with reduced case fatality, and moderate to mildly
virulent, associated with chronic or subclinical ASF [32]. Along with the virulence of
the isolate, other factors such as age [20], dose and route of infection [19,33] have been
pointed out as key for the evolution of clinical forms. Under natural conditions, ASFV is
most transmitted among pigs via contact with excreted viral particles through nuzzling
or ingestion, although tick bites, mechanical vectors, contaminated needles and other
forms of parenteral infection are also involved [34]. Experimental oronasal inoculation
mimics natural infection because it results in uptake of the ASFV via the oral and upper
respiratory mucosa; the virus interacts with mucosal surfaces and is exposed to innate
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defence mechanisms [19]. Therefore, although oronasal infections may result in less
reproducible clinical forms and more variability in clinical presentations than intramuscular
inoculations, they constitute an optimal experimental inoculation route to study the early
pathogenic mechanisms of disease and initial immune response against ASFV.
The present study provides detailed pathological data to complement previous studies
that evaluated clinical and virological parameters in domestic pigs inoculated intranasally
with different doses (high, medium and low) of the ASFV isolate Ken05/Tk1 [35]. This
ASFV isolate was obtained from a tick extracted from a warthog burrow in central Kenya
in 2005 [36]. The aims of this study were (i) to evaluate if the distribution and severity of
macroscopic and histopathological lesions as well as the distribution of viral antigen in
tissues were influenced by the different doses of virus administered and (ii) to propose
and apply a comprehensive scoring system to evaluate macroscopic and histopathologic
lesions, as well as the amount and distribution of viral antigen in tissue samples to facilitate
standardized and harmonized comparison of ASF lesions across studies.
2. Results
Pigs were euthanised upon reaching a predefined clinical score humane endpoint, at
the end of the experiment (day 21 post inoculation) or to prevent housing of single animals
(Figure 1).
Figure 1. Evolution of mortality throughout the experiment. Fifteen pigs distributed in three groups
(n = 5) we infected experimentally by intranasal route with 4.4 × 104 HAD50/mL (group A—high
dose), 4.4 × 103 (group B—medium dose) and 4.4 × 102 (group C—low dose) of ASFV isolate
Ken05/Tk1 (genotype X). Days post infection (x-axis); percent survival (y-axis).
2.1. Macroscopic Evaluation of Lesions
2.1.1. Group A—High Dose (104 HAD)
The intranasal inoculation of pigs in group A resulted in the direct infection of all
pigs except for pig 88, which was euthanised at day 12 postinoculation (pi) due to ethical
regulations to prevent housing of single animals. This animal showed late (from day 10 pi)
and low viraemia levels, but not clinical signs before termination. The rest of the animals
developed an acute form of ASF, displaying short incubation periods (ip), short clinical
courses (cc) and viraemia from day 5 pi. Pigs 87 and 90 were the first that reached humane
endpoint at day 9 pi after a short ip (5 days) and a short cc (5 days), followed by pig 86 at
day 11 pi (ip: 7 days; cc: 5 days) and pig 89 at day 12 pi (ip: 6 days; cc: 7 days) (Table 1).
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Table 1. Detection of viraemia, incubation period and clinical course in domestic pigs inoculated by
intranasal route with different doses of ASF isolate Ken05/Tk1 (Genotype X).
Pig No. Viraemia * Incubation Period Clinical Course Euthanasia
Group A—High dose (104 HAD50)
86 5 pi (low levels) 7 5 11 pi
87 5 pi (high levels) 5 5 9 pi
88 10 pi (low levels) NCS NCS 12 pi **
89 5 pi (high levels) 6 7 12 pi
90 5 pi (high levels) 5 5 9 pi
Group B—Medium dose (103 HAD50)
81 10 pi (moderate levels) 7 14 20 pi **
82 13 pi (high levels) 7 7 13 pi
83 12 pi (low levels) 17 4 20 pi
84 12 pi (low levels) 15 4 18 pi
85 12 pi (low levels) 13 4 16 pi
* First day in which viraemia was detected after infection (pi) with Ken05/Tk1 isolate. Duration of incubation
period and clinical course are given in days. ** Did not reach clinical end point; Euthanised to prevent single
housing. NCS: not observed clinical signs.
While pig 88 only displayed mild lesions of ASF commonly described at initial stages
(mild hydropericardium and ascites, mild hyperemic splenomegaly, lymphadenitis with pe-
techial haemorrhages in renal lymph nodes and haemorrhagic lymphadenitis in mesenteric
lymph nodes), the rest of the pigs showed more severe macroscopic lesions (Figure 2A).
The most relevant lesions were the presence of cyanotic and haemorrhagic areas in the
skin (tip of ears, chest, abdomen, tail, limbs and perianal area), which were more intense
in pigs 86 (Figure 3A) and 89 euthanised at days 11 and 12 pi, mild (pigs 86, 87 and 90) to
moderate (pig 89) hydropericardium, mild (pig 86) to moderate ascites (pigs 87, 89 and 90;
Figure 3B) congested, non-collapsed lungs with interstitial and alveolar oedema along with
the presence of abundant foam in trachea and bronchi (Figure 3C), mild congestion in the
liver and petechial haemorrhages in the kidney (cortex and medulla). The spleens showed
mild (pigs 86, 89 and 90) to moderate (pig 87; Figure 3D) hyperemic splenomegaly.
Haemorrhagic lymphadenitis was a common lesion, usually described in more than two
lymph nodes per animal, that affected mainly retropharyngeal, submandibular (Figure 3E),
tracheobronchial, mediastinal, gastrohepatic, renal and mesenteric lymph nodes. Other
lymph nodes that also occasionally displayed this lesion were inguinal (Figure 3F) and cer-
vical lymph nodes. Macroscopic scores were higher in pig 89 which, along with the lesions
described, also showed erythema in tonsils (Figure 3G), haemorrhages in skeletal muscles,
retroperitoneal oedema and hyperaemia of mucosal surfaces of small and large intestine.
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Figure 2. (A) Postmortem macroscopic lesion scoring. The tissues evaluated and the macroscopic
lesions observed are displayed in the graph by different colours. Score of macroscopic lesions (y-axis);
pigs evaluated in each experimental group (x-axis). (B) Median of cumulative macroscopic lesion
scores (y-axis) in each experimental group (x-axis). Narrow bars indicate maximum and minimum
values observed. Statistical analysis was carried out using the one-way ANOVA. Asterisks indicate
statistically significant differences among experimental groups of pigs (** p < 0.01).
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Figure 3. Macroscopic lesions observed in pigs infected by intranasal route with a high dose
(4.4 × 104 HAD50/mL) of ASFV isolate Ken05/Tk1 (genotype X). (A) Pig 86. Severe erythema
and cyanosis along with petechial haemorrhages on the tail. (B) Pig 89. Moderate ascites with
red-tinged fluid. (C) Pig 87. Severely congested, non-collapsed lungs with mild distension of inter-
lobular septa (interstitial oedema) and severe alveolar oedema with the presence of foamy material
in trachea. (D) Pig 87. Spleen with a moderate increase in size (moderate hyperaemic splenomegaly).
(E) Pig 87. Lymphadenopathy and haemorrhages affecting submandibular lymph nodes. (F) Pig 89.
Severe haemorrhagic lymphadenitis affecting superficial inguinal lymph nodes. (G) Pig 89. Moderate
erythema in palatine tonsils.
2.1.2. Group B—Medium Dose (103 HAD)
Only 40% of the animals in group B (pigs 81 and 82) were infected after intranasal
inoculation as indicated by viraemia levels and clinical signs. Both animals displayed
a short incubation period (7 days). Pig 82 reached the humane endpoint at day 13 pi
after a short clinical course (7 days) consistent with an acute form of ASF and displayed
high levels of viraemia. On the other hand, pig 81 survived until day 20 pi after a long
clinical course (14 days) consistent with a subacute form of ASF, displaying fluctuating
moderate clinical signs and moderate viraemia levels (Table 1). It is worth noting that
pig 81 did not reach the clinical endpoint scores and was euthanised to prevent single
housing. Pig 82 displayed macroscopic lesions and scores similar to those described
in most pigs from group A that developed a severe acute form of ASF (Figure 4A,B),
also displaying a more congested liver, moderate to severe oedema of the gallbladder
wall along with hyperaemia and haemorrhages in the gallbladder mucosa (Figure 4C).
Meanwhile, although the clinical course of pig 81 was consistent with a subacute form of
ASF, macroscopic scores (Figure 2A) were low, primarily characterised by the presence of
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generalized lymphadenitis with occasional presence of petechial haemorrhages or mild
hyperemic splenomegaly, lesions characteristic of the moderate acute, rather than subacute,
form of ASF.
Figure 4. Macroscopic lesions observed in pigs infected by the intranasal route with a moderate
dose (4.4 × 103 HAD50/mL) of ASFV isolate Ken05/Tk1 (genotype X). (A) Pig 82. Moderate hy-
dropericardium with reddish fluid. (B) Pig 82. Moderately congested, non-collapsed lungs with
mild distension of interlobular septa (interstitial oedema). (C) Pig 82. Moderate hepatomegaly
with diffuse congestion, haemorrhagic lymphadenitis of gastrohepatic lymph nodes (arrow) and
haemorrhages (arrowhead) on the serosa surface of the gall bladder. (D) Pig 85. Erythema and
cyanosis in the tips of ears. (E) Pig 83. Moderate ascites with yellowish fluid. (F–H) Pig 85. Lym-
phadenopathy and haemorrhages affecting submandibular lymph nodes (F), ileocaecal lymph node
(G) and renal lymph nodes (H). (I) Pig 83. Multifocal petechial haemorrhages in thymus. (J) Pig 85.
Kidney displaying mild congestion in renal cortex and medulla along with moderate oedema in renal
pelvis (arrowheads).
As per their viraemia and clinical signs [35], pigs 83, 84 and 85 were indirectly infected
by contact with infected animals after the intranasal inoculation of group B. Clinical signs
were first observed at day 13 pi (pig 85), 15 pi (pig 84) and 17 pi (pig 83). Disease then
developed rapidly and the animals were euthanised at day 16, 18 and 20 pi after a short
clinical course of 4 days (Table 1). However, while pigs 83 and 85 displayed high viraemia
levels at termination along with macroscopic lesions characteristic of severe acute forms of
ASF (Figure 4D–J), pig 84 showed clinical alterations without temperature increase, very
low viraemia levels and low macroscopic scores (Figure 2A), characterised by the presence
of mild hydropericardium, mild ascites and generalized lymphadenitis with the presence
of petechial haemorrhages. Pig 84 also displayed fibrinous pericarditis and fibrinous
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exudate on serosal surfaces of abdominal cavity organs, lesions that were associated with
the presence of concomitant or secondary bacterial infections.
2.1.3. Group C—Low Dose (102 HAD)
All pigs in group C (102 HAD) remained clinically normal throughout the experiment
and the viral genome was not detected in blood samples of animals within this group. Pigs
were euthanised at the end of the experiment (day 21 pi). Necropsies revealed the presence
of nonspecific, mild macroscopic changes, such as lymphadenitis, affecting only some
lymph nodes or hepatic congestion not suggestive or characteristic of ASF (Figure 2A).
Statistical analysis revealed significant differences among the macroscopic scores
observed in groups A and B, regarding group C (p < 0.01), but not between groups A and B
(Figure 2B).
2.2. Histopathological Evaluation of Lesions
Tissues samples from the three pigs with the highest macroscopic scores within
each experimental group were selected for additional histopathological evaluations and
immunohistochemical studies focused on determining viral antigen distribution. Tissue
samples were collected from skin (ventrolateral abdominal area), lung (right cranial and
caudal lobes), distal ileum, ileocaecal valve, colon, liver, kidney, spleen, thymus, tonsil, bone
marrow and lymph nodes (submandibular, retropharyngeal, tracheobronchial, ileocaecal,
gastrohepatic and renal).
2.2.1. Group A—High Dose (104 HAD) and Group B—Medium Dose (103 HAD)
In concordance with macroscopic evaluations, the histopathological study revealed
the severe lesions characteristic of ASF in all pigs evaluated in group A (87, 89 and 90) and
B (82, 83 and 85). Histopathological scores (Figure 5A) were especially high in all pigs from
group A infected with the highest dose of Ken05/Tk1 (104 HAD) and in pig 82 from group
B (103 HAD).
In the skin (Figure 6A,C), the lesions were mild and mainly observed in the der-
mis (hyperaemia with occasional minimal focal haemorrhages, vasculitis and minimal
perivascular and intravascular accumulation of monocytes), although without significant
differences between pigs in group A and B.
In the lungs (Figure 6D), along with the presence of diffuse moderate hyperaemia, ang-
iectasia and thickening of alveolar septa, all pigs selected from group A and B also showed
scattered mild alveolar haemorrhages, diffuse moderate alveolar oedema along with the
presence of cell debris, fibrin deposits, macrophage infiltrates and the occasional presence
of megakaryocytes in alveolar lumen. Some small and medium vessels showed mild
oedema in tunica media along with prominent diffuse endothelial activation characterised
by endothelial cell hypertrophy and rounded nuclei. Moderate, scattered peribronchial
and peribronchiolar mononuclear infiltrates were also described. Pig 90 also showed
microthrombosis in some vessels. Pigs infected with the highest dose (Group A) displayed
diffuse, moderate to severe interstitial oedema, along with mild pleural thickening and
occasional presence of pleural or subpleural haemorrhages, histopathological changes that
were more severe than those observed in pigs from group B.
The differences in the severity of the lesions described in the distal ileum (mild
diffuse hyperaemia in submucosa with presence of small and medium size vessels with
intramural inflammatory infiltrates (Figure 6H), mild diffuse lymphocytic depletion of
Peyer’s patches and interfollicular areas (Figure 6I) were not remarkable between the pigs
from groups A and B. However, vascular changes, lymphocytic depletion and cellular
fragmentation phenomena observed in the ileocaecal valve sections (Figure 7A) were
more severe in pigs infected with the highest dose of Ken05/Tk1 (group A). In the colon,
lesions in pigs in group A were also more severe and characterised by the presence of mild
diffuse hyperaemia with occasional haemorrhages in the epithelium, the presence of mild
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multifocal mononuclear infiltrates in lamina propria (Figure 7C,D) and severe hyperaemia
and oedema in submucosa.
In the liver, similar lesions were observed in pigs from group A and B. Histopatholog-
ical changes (Figure 7F) were characterised by the presence of mild, diffuse congestion and
expanded hepatic sinusoids, moderate, diffuse interstitial lymphoplasmacytic infiltrates in
portal spaces and interlobular areas with presence of mild cellular fragmentation, scattered,
small foci of lymphoplasmacytic infiltrates in hepatic sinusoids, moderate, diffuse sinu-
soidal leukocytosis with presence of enlarged Kupffer cells in hepatic sinusoids and small,
scattered, necrotic foci of hepatocytes. Prominent endothelial activation was accompanied
by vasculitis with intramural inflammatory mononuclear infiltrates and mononuclear
perivasculitis that affected mainly arteries and veins in portal spaces.
Figure 5. (A) Histopathologic lesion scoring. The tissues evaluated and the histopathologic lesions observed are displayed
in the graph by different colours. Score of histopathologic lesions (y-axis); Pigs evaluated in each experimental group
(x-axis). (B) Median of cumulative histopathologic lesion scores (y-axis) in each experimental group (x-axis). Narrow
bars indicate maximum and minimum values observed. (C) Scores of cells immunolabeled for ASFV specific antigen
p30/CP204L. The tissues evaluated and the scores of cells immunolabeled are displayed in the graph by different colours.
Score of immunolabeled cells (y-axis); Pigs evaluated in each experimental group (x-axis). (D) Median of immunolabeled
cell scores (y-axis) in each experimental group (x-axis). Narrow bars indicate maximum and minimum values observed.
Statistical analysis was carried out using the one-way ANOVA. Asterisks indicate statistically significant differences among
experimental groups of pigs (** p < 0.01; *** p < 0.001; **** p < 0.0001).
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Figure 6. Histopathologic lesions observed in pigs infected by the intranasal route with high
(4.4 × 104 HAD50/mL) and moderate (4.4 × 103 HAD50/mL) doses of ASFV isolate Ken05/Tk1
(genotype X). (A,B) Serial sections of skin; (A) HE stain, 20x. Mild perivascular mononuclear in-
filtrates (arrowheads) in dermis (d). (B) IHC, 20×. Macrophages (arrows) immunolabeled against
viral antigen in perivascular infiltrates in dermis (d) along with endothelial cells positively immuno-
labeled (arrowheads). (C) HE stain, 40×. Capillary endothelial cells displaying hypertrophy with
rounded nuclei (arrowheads) and vasculitis along with perivascular mononuclear infiltrates with
the presence of pyknotic cells and cell debris. (D,E) Serial sections of lung. (D) HE stain, 10×.
Moderate hyperaemia, septal thickening and alveolar proteinaceous oedema along with moderate
pleural thickening (arrow). (E) IHC, 10×. Scattered cells immunolabeled against viral antigen in the
pulmonary parenchyma. (F) IHC, 20×. Septal thickening and presence of alveolar macrophages (thin
arrows), pulmonary intravascular macrophages (large arrowheads), interstitial macrophages (small
arrowheads) and endothelial cells (thick arrow) immunolabeled for viral antigen. (G) IHC, 10×.
Macrophages immunoreactive against viral antigen infiltrating the bronchus-associated lymphoid
tissue (BALT) (arrow) and in the alveolar septa. (H) Distal ileum, HE, 4×. Mild diffuse hyperaemia
in submucosa (sm); Insert: HE, 20×. Medium size vessel in submucosa with vasculitis. (I,J) Serial
sections of distal ileum. (I) HE, 4×. Mild lymphocytic depletion of lymphoid follicles (lf ). (J) IHC,
4×. Cells immunolabeled for viral antigen mainly in interfollicular areas (ia) and peripheral areas of
lymphoid follicles (lf ). Haematoxylin-eosin staining (HE); immunohistochemistry against protein
(IHC); original magnification (number ×).
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Figure 7. Histopathologic lesions observed in pigs infected by the intranasal route with high
(4.4 × 104 HAD50/mL) and moderate (4.4 × 103 HAD50/mL) doses of ASFV isolate Ken05/Tk1
(genotype X). (A,B) Serial sections of ileocaecal valve. HE, IHC, 4×. Mild diffuse hyperaemia in
submucosa, mild lymphocytic depletion of lymphoid follicles and cells immunolabeled for viral
antigen mainly in lamina propria (lp), interfollicular areas (ia) and peripheral areas of lymphoid
follicles (lf ). (C) Colon HE, 4×. Moderate mononuclear infiltrates in lamina propria (lp) and moder-
ate hyperaemia and oedema in the submucosa (sm). (D,E) Serial sections of colon. HE, IHC, 20×.
Mononuclear infiltrates in lamina propria along with the presence of cells, mainly macrophages,
immunolabeled against viral antigen. (F,G) Serial sections of liver. HE, IHC, 10×. Interstitial
mononuclear infiltrates in portal spaces (arrow) and hepatic parenchyma (small arrowhead) along
with sinusoidal leukocytosis. Observe the presence of mononuclear cells in the infiltrates (arrow),
hepatocytes (large arrowheads) and endothelial cells (small arrowheads) immunolabeled against
viral antigen. (H) Liver. IHC, 20×. Presence of enlarged Kupffer cells (arrows) and hepatocytes
(arrowheads) immunolabelled positively for viral antigen. (I) Kidney. HE, 10×. Severe diffuse
interstitial congestion, multifocal haemorrhages along with necrotizing vasculitis with presence of
microthrombi and perivascular oedema in renal cortex. (J,K) Serial sections of kidney. HE, IHC,
10×. Interstitial inflammatory mononuclear infiltrates (arrow) in renal cortex and cells positive
for viral antigen, mainly macrophages, within the inflammatory infiltrates. (L) Kidney. HE, 4×.
Severe focal interstitial haemorrhage (arrow) and diffuse moderate interstitial oedema in renal pelvis.
(M) Kidney. HE, 10×. Tubulonephrosis (arrows) and focal tubular necrosis (arrowheads) in renal
cortex. (N) Kidney. IHC, 20×. Presence of a circulating monocyte (arrow) and a capillary endothelial
cell (arrowhead) immunolabeled against viral antigen within a glomerulus. Haematoxylin-eosin
staining (HE); immunohistochemistry against p30/CP204L protein (IHC); original magnification
(number ×).
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Pigs from group A showed more severe lesions in the kidney than pigs in group
B, characterised by the presence of mild to moderate, diffuse congestion and multifocal,
interstitial haemorrhages in both the renal cortex (Figure 7I), medulla and renal pelvis
(Figure 7L). Pig 87 (group A) also had evident interstitial oedema in the renal cortex. Mul-
tifocal interstitial mononuclear infiltrates, mainly observed in the renal cortex (Figure 7J),
were also more severe in pigs from group A, which also displayed protein rich fluid in
Bowman’s space and tubules due to the leakage from damaged glomeruli. Pigs 83 (group B)
and 87 (group A) also displayed focal, fibrinonecrotic glomerulonephritis, focal, mild to
severe tubulonephrosis with intratubular hyaline droplets as well as focal tubular necrosis
(Figure 7M). Microthrombi, along with intramural inflammatory infiltrates, were also ob-
served in these pigs, along with severe, focal, necrotizing vasculitis of renal arterioles in
pig 89 (Figure 7I).
In the spleen, all pigs in group A (87, 89, 90) and pig 82 in group B showed severe,
diffuse lymphocytic depletion of splenic white pulp along with a severe, diffuse, engorge-
ment of red pulp (Figure 8A). The splenic red pulp appeared full of mononuclear cells, cell
debris and fibrin deposits. The presence of megakaryocytes was also observed. Lymphoid
follicles and periarteriolar lymphoid sheaths were small and difficult to discern, appearing
to be infiltrated by erythrocytes and macrophages, many of them with abundant cytoplasm
containing phagocytized cell debris (tingible bodies), and showing a severe, lymphocytic
depletion along with abundant pyknotic cells and cell debris (Figure 8C).
Figure 8. Histopathologic lesions observed in pigs infected by the intranasal route with high
(4.4 × 104 HAD50/mL) and moderate (4.4 × 103 HAD50/mL) doses of ASFV isolate Ken05/Tk1
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(genotype X). (A,B) Serial section of spleen. HE, IHC, 10×. Severe, diffuse engorgement of the
splenic red pulp (rp), lymphoid follicle (lf ) infiltrated by erythrocytes displaying moderate lymphoid
depletion and presence of a high number of cells, mainly hypertrophic macrophages, immunolabelled
against viral antigen in the splenic red pulp (rp), marginal zone (mz) and within lymphoid follicles
(lf ). (C) Spleen. HE, 20×. Detail of lymphoid follicle showing moderate lymphoid depletion along
with abundant pyknotic cells, cell debris and macrophages infiltrates. (D,E). Serial sections of
thymus. HE, IHC, 10×. Severe, diffuse presence of tingible body macrophages with abundant
cytoplasm containing cell debris in cortex (co), giving rise to the so-called ‘starry sky’ appearance.
Cells immunolabeled for viral antigen, mainly macrophages, in cortex (co) along with the presence of
macrophages and star-shaped cells in the medulla (me) and corticomedullary junction. (F) Thymus,
HE, 10×. Severe atrophy of cortex and presence of Hassall’s corpuscles (arrows) at the surface of
the organ. (G,H) Serial sections of palatine tonsils. HE, IHC, 4×. Moderate lymphoid depletion in
lymphoid follicles (lf ) and interfollicular areas (ia). Cells, mainly macrophages and some lymphocytes,
immunolabeled for viral antigen in interfollicular areas and around lymphoid follicles. (I,J) Serial
sections of palatine tonsil. HE, IHC, 10×. Detail of a crypt showing a severe infiltrate of mononuclear
cells, which display pyknosis and cell fragmentation. Observe the massive infiltration of cells, mainly
macrophages and lymphocytes, immunolabeled for viral antigen in the epithelium of the crypt. Serial
sections of bone marrow. HE, IHC, 20× (K,L) and 10× (M,N). Observe the severe hypocellularity
and the scarce number of megakaryocytes (arrows) in (M) compared with (K). Insert (HE, 20×).
Presence of pyknotic cells, cell fragmentation and fibrin strands. Viral antigen was mainly detected in
monocytes and macrophages (arrows) and, occasionally in megakaryocytes (large arrowheads) and
capillary endothelial cells (small arrowheads). (O,P) Serial sections of renal lymph node. HE, IHC, 4×.
Moderate lymphoid depletion of lymphoid follicles (lf ) and diffuse lymphoid tissue along with severe
haemorrhages in medullary cords. Cells immunolabeled for viral antigen were mainly observed in
the medulla (me) and interfollicular areas of the cortex. The presence of cells immunolabelled within
lymphoid structures was lower. (Q) Gastrohepatic lymph node. HE, 4×. Severe lymphoid depletion
of lymphoid follicles, which appear massively infiltrated by erythrocytes. (R,S) Serial sections of renal
lymph node. HE, IHC, 10×. Detail of lymphoid follicle (lf ) displaying moderate lymphoid depletion
along with the presence of abundant pyknotic cells, cell fragmentation and macrophage infiltrates.
Observe the high number of cells immunolabeled against viral antigen mainly in medulla (me) and
marginal zone (mz) of the lymphoid follicle. (T) Gastrohepatic lymph node. HE, 10×. Lymphoid
follicle (lf ) displaying severe lymphoid depletion and infiltration of erythrocytes. (U) Renal lymph
node, HE, 20×. Vasculitis and severe perivascular haemorrhages. Haematoxylin-eosin staining (HE);
immunohistochemistry against p30/CP204L protein (IHC); original magnification (number ×).
In the thymus, cortex atrophy was the most significant change observed. Most of
the pigs in group A and B showed mild to moderate, diffuse lymphocytic depletion. The
cortex appeared full of pyknotic cells and cell fragmentation along with a moderate to
severe, diffuse presence of tingible body macrophages (TBM) (Figure 8D). Occasional small
haemorrhages were also present. In pig 89 (group A), lymphocytic depletion was especially
severe, resulting in the prominence of Hassall’s corpuscles at the surface of the organ
(Figure 8F), while images of cell debris and TBM were less frequent.
The tonsils showed diffuse, moderate to severe lymphocytic depletion (Figure 8G)
that affected both lymphoid follicles and interfollicular areas, changes that were more
severe in pigs of group A (87, 89 and 90) and in pig 82 (group B). Lymphocytic depletion
was accompanied by the presence of pyknotic cells, cell fragmentation and TBM infiltrates,
the latter especially abundant within the lymphoid follicles. Connective tissue proliferation
was also a characteristic change observed in interfollicular areas. The epithelium of the
crypts showed moderate to severe infiltrates of mononuclear cells which also displayed
pyknosis and cell fragmentation (Figure 8I).
In the bone marrow diffuse, moderate to severe hypocellularity with occasional
presence of fibrin strands, focal haemorrhages (Figure 8K,M), endothelial activation in
small and medium size vessels and a low number of megakaryocytes were observed. The
Pathogens 2021, 10, 768 14 of 23
changes were especially marked in pig 82 (group B) and 89 (group A). Pyknosis and cell
fragmentation were scarce.
Finally, all pigs in groups A and B showed severe histopathological lesions in the
submandibular, retropharyngeal, gastrohepatic and renal lymph nodes (LNs). All pigs
in group A (87, 89, 90) and pig 82 in group B also showed severe histopathological le-
sions in the tracheobronchial lymph nodes, while lesions in the ileocaecal lymph nodes
were mild to moderate. Diffuse, moderate to severe haemorrhages that mainly affected
medullary cords and diffuse lymphoid tissue in the cortex were observed. Marginal zones
of lymphoid follicles in the cortex and germinal centres usually were infiltrated with
blood. In addition, there was moderate to severe lymphocytic depletion that affected
both the lymphoid follicles and diffuse lymphoid tissue, accompanied by a massive pres-
ence of pyknotic cells and cell fragmentation, which was also observed in the medulla
(Figure 8O,Q,R,T). Megakaryocytes were usually observed among haemorrhages and cell
debris. Capillary and small-vessel endothelial cells displayed cellular hypertrophy and the
rounded, prominent nuclei characteristic of endothelial activation. Occasionally, vasculitis
with intramural inflammatory infiltrates, necrosis of endothelial cells, perivascular oedema
and fibrin deposits in the vascular lumina were also observed (Figure 8U).
2.2.2. Group C—Low Dose (102 HAD)
In group C (102 HAD), the histopathological evaluation revealed nonspecific le-
sions and mainly mild vascular changes in the lung, liver and kidney of pigs 77 and
79 (Figure 5A). Pig 77 also showed mild histopathological changes in the thymus (cortical
atrophy and lymphocytic depletion in the medulla) as well as in the tonsils and some
lymph nodes (retropharyngeal, tracheobronchial, ileocaecal and gastrohepatic), which
displayed mild, diffuse hyperaemia with occasional haemorrhages along with mild to
moderate lymphocytic depletion that affected mainly lymphoid follicles.
Statistical analysis revealed significant differences in the histopathological scores of
groups A and B with respect to group C, but not between groups A and B (Figure 5B).
2.3. Evaluation of Viral Antigen Distribution
The presence of cells immunolabeled for the ASF-specific antigen p30/CP204L was
not detected in any of the tissues taken from the pigs included in group C (102 HAD).
On the other hand, the viral antigen was detected in most of the tissues evaluated from
pigs in groups A and B. Pigs 87 and 90 (group A) and pig 83 (group B) displayed the
highest presence of immunolabeled cells (Figure 5C). However, statistical analysis did
not reveal significant differences regarding immunolabeled cells between groups A and
B (Figure 5D). Circulating monocytes and macrophage populations of different tissues,
along with endothelial cells of small vessels and capillaries, were the main target cells of
the virus, with high numbers of cells immunolabeled in lungs, liver and lymphoid organs.
Immunolabeled cells, mainly endothelial cells, circulating monocytes, macrophages
within perivascular infiltrates and reticular cells, were observed in the dermis of skin
sections (Figure 6B), with pigs 87 and 90 (group A) displaying particularly high numbers.
In the lungs, viral antigen was detected mainly in the pulmonary intravascular
macrophages (PIMs) and, to a lesser degree, in the pulmonary alveolar macrophages
(PAMs). Endothelial cells of small vessels and capillaries were also immunolabeled
(Figure 6E,F). The viral antigen was also detected in pneumocytes. Positive cells, mainly
macrophage-like cells, were occasionally observed infiltrating the bronchus-associated
lymphoid tissue (BALT) of some animals (Figure 6G). Differences regarding the nature and
amount of immunolabeled cells were not observed between cranial and caudal lobes.
A high number of positive cells was observed in some intestinal areas of pigs 87 and
90 (group A). Immunolabeled cells, mainly macrophages and occasionally lymphocytes,
were located in the lamina propria and interfollicular areas of the submucosa of the distal
ileum (Figure 6J) and ileocaecal valve (Figure 7B), and also in the lamina propria and
submucosa of the colon (Figure 7E).
Pathogens 2021, 10, 768 15 of 23
In the liver, circulating monocytes and Kupffer’s cells within hepatic sinusoids,
macrophages within interstitial infiltrates, mainly in portal spaces and interlobular ar-
eas, along with a high number of hepatocytes, were immunolabeled. Endothelial cells
immunolabeled for viral antigen were also observed mainly in capillaries and small-size
vessels in portal spaces, hepatic sinusoids and, occasionally, in central veins (Figure 7G,H).
In the kidney, antigen-positive cells, mainly macrophages, were observed within the
multifocal interstitial mononuclear infiltrates of the renal cortex and medulla (Figure 7K).
Within the glomeruli, capillary endothelial cells, circulating monocytes and mesangial cells
were also occasionally immunolabeled (Figure 7N). The presence of immunolabeled cells
was especially high in pig 87 (group A) and pigs 83 and 85 (group B).
In the spleen, red pulp showed a massive presence of immunolabeled macrophages,
most of them showing an increase in size. Lymphocytes labeled for viral antigen were
also frequently observed in this area. Immunolabeled cells also appeared in peripheral
areas of splenic lymphoid follicles and less frequently within lymphoid follicles (Figure 8B).
Occasionally, star-shaped cells, likely reticular or follicular dendritic cells, were positive for
viral antigen within splenic lymphoid follicles.
In the thymus, macrophages, which also showed an increase in size, were the main
target cells. The presence of positive cells was especially high in the corticomedullary
junction. Occasionally, lymphocytes and star-shaped cells in both the cortex and medulla
were also immunolabeled (Figure 8E).
In the tonsils, the highest number of cells immunolabeled for viral antigen, mainly
macrophages and some lymphocytes, was observed infiltrating the epithelium of the
crypts and in the diffuse lymphoid tissue around the crypts. Tonsillar epithelium was also
positive. A high number of labeled cells, mainly macrophages and some lymphocytes, were
also observed in interfollicular areas, while the presence of antigen positive cells inside
lymphoid follicles was lower (Figure 8H,J). Immunoreactive star-shaped, likely reticular or
dendritic cells, were also observed in interfollicular areas and within lymphoid follicles.
Myeloid cells were the main target cells in the bone marrow, while the presence of
immunolabeled megakaryocytes and granulocytic cells was low (Figure 8L,N).
Regarding the lymph nodes, the ileocaecal lymph nodes generally showed a lower
presence of immunoreactive cells. The rest of the evaluated lymph nodes displayed a
high number of immunolabeled cells, mainly macrophages and some lymphocytes, that
were mainly observed in the medulla and interfollicular areas of the cortex, while the
presence of positive cells within the lymphoid follicles was low (Figure 8P,S). Star-shaped,
immunolabeled cells were also observed occasionally in interfollicular areas and within
lymphoid follicles. In areas with severe haemorrhages and lymphocytic depletion, the
presence of immunolabeled cells was very low.
3. Discussion
As reported previously [35], the intranasal inoculation of the Ken05/Tk1 isolate with
a dose of 4.4 × 104 HAD resulted in the direct infection of 80% of the animals (four out
of five pigs). The pigs developed typical acute forms of ASF [32,37,38] characterised by
short clinical courses (from 5 and 7 days) before reaching the clinical endpoint between
day 9 and 12 pi. Even pig 88, likely infected indirectly by contact with pen mates and
euthanised at day 12 pi due to ethical considerations but without clinical signs, showed
viraemia levels and macroscopic lesions commonly described in the initial stages of acute
ASF forms [32,33]. These changes may have agreed with an outcome equivalent to that of
its pen mates within the next 2 to 4 days.
In contrast, only 40% of the animals (two out of five pigs) were directly infected after
the administration of a 10-fold lower dose (4.4 × 103 HAD). These animals also showed
slightly longer incubation periods of 7 days and lower and delayed viraemia levels than
those detected in most of the pigs directly infected after the administration of a higher dose.
On the other hand, the clinical and virological data observed from day 12–13 pi suggested
that the other three of the five animals within this group inoculated with 103 HAD did
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not actually develop a long incubation period, but rather became infected indirectly by
contact with their pen mates [35]. Regardless of whether pigs inoculated with 103 HAD
had become infected directly or indirectly, all except one (pig 81) developed a short clinical
course (from 4 to 7 days) before euthanasia as well as macroscopic lesions similar to those
described in pigs from group A infected with 104 HAD and characteristic of acute forms of
ASF [32,37,38].
As mentioned, only pig 81 developed a long clinical course (14 days) with fluctuating
clinical signs and moderate viraemia levels. Such a clinical course was consistent with
a subacute, rather than acute, form of ASF. However, this animal was euthanised before
reaching a humane endpoint due to ethical considerations to prevent single animal housing.
This pig showed lesions and lower macroscopic scores that corresponded to acute, rather
than subacute, forms of ASF [32]. If this pig had been allowed to live longer, two possible
outcomes would have been plausible. Pig 81 might have recovered or, alternatively, a
moderate clinical course with fluctuating clinical signs and moderate viraemia levels
could have been extended until an ultimately fatal outcome where lesions may then have
been more consistent with a subacute form. Animals that develop this kind of subacute
course of disease usually display more severe and widespread haemorrhages and oedema,
and therefore higher gross pathology scores, than those described in acute forms [32,38].
Subacute lesions are usually accompanied by severe leukopenia, severe thrombocytopenia
and erythrodiapedesis due to vasodilation phenomena [13,39,40]. Finally, it is important
to note that the presence of high lesion scores in pigs may not be directly linked to highly
virulent isolates because acute ASF forms induced by highly virulent isolates usually
display fewer lesions than subacute forms induced by moderately virulent isolates, where
widespread haemorrhages and oedemas are frequent.
Preliminary, but independent, studies where domestic pigs, 10–12 weeks old, were
inoculated by intramuscular [31] and intranasal route [41] with a low dose (10 HAD) were
carried out to determine the virulence of the Ken05/Tk1 isolate. The results suggested
that the route of infection influenced the evolution and outcome of the clinical forms. In
such studies, animals inoculated intranasally that did not reach the end of the experiment
(euthanised or died between day 12 and 21 pi) showed a delay in both the appearance of
viraemia and clinical signs (between day 7 and 14 pi). This was coupled with longer clinical
courses than pigs infected intramuscularly which became viremic from day 3 pi, displayed
clinical signs from day 6–7 pi and were euthanised or died between day 11 and 18 pi. In
the previous experiments, regardless the route of infection, 50% of animals survived until
the end of the experiments, displaying both mild clinical signs and low viraemia levels.
Although pigs infected intramuscularly that reached the end of the experiment (day 70 pi)
displayed the severe haemorrhagic lesions characteristic of subacute ASF, along with a
high presence of infected cells detected by immunohistochemistry in tissues [31], the pigs
intranasally inoculated showed no lesions and hardly any presence of infected cells in
tissues [41]. These results suggest a possible role of mucosa -associated lymphoid tissue
(MALT) in the selective absorption of the virus, as well as in the induction of an immune
response capable of modulating and controlling virus replication and spread [33,42]. ASFV
replication in MALT has been detected as early as 24 h pi and prior to systemic dissemina-
tion [19,43,44]. However, the nature of local immune responses triggered in MALT at initial
virus replication stages and their systemic consequences are unclear. Further comparative
studies, between highly and moderately virulent isolates, focusing on the initial stages of
infection are required to understand these mechanisms.
In previous studies, after intranasal infections with a low dose of Ken05/Tk1 (10 HAD),
50% of pigs showed viraemia, clinical signs and were euthanised displaying characteristic
lesions of subacute ASF [41]. In contrast, in the present study all animals inoculated in-
tranasally with the lowest dose (102 HAD) survived until the end of the experiment without
showing clinical signs, lesions or detectable levels of the virus genome in blood. Such
differences may be attributed not only to experimental design and the titration methods
used by different laboratories, but also to other factors likely associated with the nature and
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pathogenicity of moderately virulent isolates that can lead to a greater level of variation in
results. Similar variable results have been described in the course of experimental infections
with other moderately virulent ASFV isolates that were administered intranasally at the
same dose (3.5 log10 median tissue culture infective dose-TCID50/mL) to domestic pigs of
the same age (12 weeks old). In these experiments, mortality rates ranged from 0% [18] to
100% by day 15 pi [20].
The difficulty of carrying out comparative intranasal inoculations with medium and
high doses of moderately virulent ASFV isolates has been previously highlighted [18].
In that study, three groups of domestic pigs (12 weeks old) were housed in separate
compartments and five pigs in each group were inoculated intranasally with a moderately
virulent isolate, either the Malta’78 (3 log10 TCID50) (medium dose) or 4 log10 TCID50
(high dose) per pig) or the Netherlands’86 (3.5 log10 TCID50 per pig) isolate. In both the
Malta’78 medium dose group and the Netherlands’86 group, the inoculation was successful
in three of the five pigs, and the remaining pigs were considered contact exposed. In the
Malta’78 high dose group, the inoculation was successful in all five pigs. Inoculation
successes were similar to those described with medium and high doses of Ken05/Tk1
in the present experiment. However, while most of pigs inoculated with Malta’78 and
Netherlands’86 survived up to day 70 pi, showing low viraemia levels but not clinical
signs, pigs inoculated with medium and high doses Ken05/Tk1 developed clinical courses
and had to be euthanised between day 9 and 20 pi, suggesting a higher virulence than for
the Malta and Netherlands isolates.
Most of the information available regarding isolates classified within genotype X is
focused on their molecular characterization [36,45,46], with few references to experimental
studies focused on evaluating their virulence and clinical courses in pigs. In a comparative
experimental infection, indigenous domestic African pigs and European genetic lineage
pigs of the same age (6 months old) were inoculated intranasally with 10 HAD of ASFV
Ken05/K2 domestic pig isolate [47]. Indigenous African pigs displayed a delay in the
incubation period and in the appearance of viraemia. In contrast to European lineage pigs,
which displayed high temperatures and died or were euthanised between day 13 and 21 pi,
indigenous African pigs showed inconsistent clinical signs without high temperatures and
died or were euthanised between day 18 and 32 pi. During macroscopic evaluations, in-
digenous African pigs displayed more severe and widespread haemorrhages and oedemas
than European lineage pigs, which were characteristic of subacute forms of ASF. Virus titers
in the spleen and lymph nodes were also lower than those detected in European lineage
pigs. These results demonstrated that in addition to other factors like age, route of infection,
dose and virulence of the ASFV isolates [20,32], breed and the genetic background of the
host also play a key role in the evolution of ASF clinical forms.
Unusual or unexpected virological and immunological responses against genotype
X isolates have also been discussed in different studies. Three of ten European domestic
pigs oro-nasally infected with the moderately virulent ASFV isolate Ken05/K2 did not
exhibit an antibody response whilst in the remaining animals, an antibody response was
initiated between days 10 and 23 pi. [48]. Other studies carried out in East Africa described
the presence of apparently asymptomatic local domestic pigs positive for ASFV by PCR in
tissues (virus isolates belonging to genotypes IX and X), but negative for ASFV in blood
by PCR and serology. These results suggest a potential role of carrier domestic pigs as a
source of infection [49,50]. However, whether animals positive for ASFV by PCR in tissues
were also capable of transmitting the disease to uninfected, naïve pigs was not investigated.
It has been suggested that ASFV may persist for long periods in tissues or blood from
recovered pigs or following infection with moderate-to-low virulence isolates, contributing
to disease persistence in endemic areas and causing sporadic outbreaks or introduction
into disease-free zones [51,52].
On the other hand, an extensive literature review found no evidence of a role for long-
term carriers in transmission [53]. In the present experiment, in addition to the absence of
detectable levels of the virus genome in blood samples from pigs infected with the lowest
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dose (102 HAD) of Ken05/Tk1 throughout the experiment, the absence of viral antigen in
tissue samples did not support the existence of possible carriers or persistently infected
pigs, at least for the 21 day period of the study.
The evaluation protocols used in the present study were modified and adapted from
previous protocols [37] to include (i) a simplified pathological evaluation criteria, accompa-
nied by a gross lesions scoring chart that was easy to fill out; (ii) a broader scoring system
including a wider number of organs; (iii) a precise scoring system that includes scoring
of lesions typically described in the subacute and chronic forms of ASF, not evaluated in
previous protocols; (iv) the addition of a protocol to score results of IHC. The protocols
proposed allowed accurate standardized pathological assessments to be carried out and
contributed to faster evaluation procedures at necropsy. The scoring sheets provided in the
Supplementary Materials are simple and self-explanatory. Additionally, the integration of
all scorings (clinical, macroscopic lesions, histopathological lesions and immunohistochem-
ical ASFV specific staining) provided a thorough picture of the presentation and severity of
disease in individual animals. Semiquantitative scorings also allowed comparison between
animals and groups.
Regarding the pathological evaluations, two pigs inoculated with medium and high
doses of Ken05/Tk1 (pigs 82 and 89) that displayed severe lesions and the highest macro-
scopic and histopathological scores, showed the lowest number of cells immunolabeled
for viral antigen in tissues. This fact corroborates that the severity and extension of le-
sions may not be directly related with the amount of virus present in the tissue but with
indirect mechanisms triggered by ASFV as previously suggested [38,54]. Because lesions
and viral antigen distribution in tissues were only evaluated in samples taken when the
humane endpoint was reached and not at early stages, viral spread and the evolution of
the pathogenic mechanisms of lesions induced by the Ken05/Tk1 isolate require further
study. The viral antigen was detected in all the tissues evaluated from the pigs selected
in the groups infected with the medium and high doses without significant differences
in the amount of immunolabeled cells. Along with the monocytes−macrophages, which
are considered to be the main ASFV target cells [12,17,55], and the endothelial cells of
small vessels and capillaries, many other cells were immunolabeled for viral antigen
p30/CP204L and morphologically identified in the selected tissues. Among them were
hepatocytes, lymphocytes, star-shaped cells (likely reticular or dendritic cells), tonsillar
epithelium, megakaryocytes and granulocytic cells. Infection or replication of ASFV in
these cells usually takes place only in the final stage of the disease without any apparent
major role in the pathogenesis of the disease. Contradictory studies have suggested that
the expression of specific markers associated with the maturation stages of macrophages,
such as CD163, might increase their susceptibility to ASFV infection [56,57]. It has also
been speculated that infection of nonmacrophage cells might be favoured by the expression
of ASF virus-membrane receptors when monocytes−macrophages are still present and
undergoing intense proliferation [38,58]. However, both the mechanisms and the role of
receptors regarding a cell’s susceptibility to ASFV infection remain unclear.
4. Materials and Methods
4.1. Experimental Design, Clinical Evaluations, Sampling and Quantification of Viral DNA
Details of experimental design, clinical evaluations, sampling and quantification of
viral DNA levels in blood samples from the domestic pigs presented in this study have
been previously described [35]. Animal experiments were carried out in the biosafety level
3 (BSL3) facilities at Animal and Plant Health Agency (APHA, Weybridge, UK). Fifteen
Large White pigs were housed and grouped into three groups of five animals. Animals
were inoculated at 12 weeks of age, after a period of acclimatisation, using intranasal
mucosal atomisation devices (MAD Intranasal, Teleflex), with 2 mL (1 mL per nostril) of
ASFV isolate Ken05/Tk1. The doses inoculated were 4.4× 104 HAD50/mL (group A—high
dose; pigs 86 to 90), 4.4 × 103 (group B—medium dose; pigs 81 to 85) and 4.4 × 102 (group
C—low dose; pigs 76 to 80), respectively. To simplify, throughout the manuscript we will
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refer to the experimental groups as group A (104 HAD), group B (103 HAD) and group C
(102 HAD).
Experimental infection day was defined as day 0. After inoculation, clinical signs and
rectal temperatures were monitored daily. Blood samples were taken prior to inoculation,
then at 2- or 3-day intervals post inoculation into EDTA vacutainers (BD biosciences, Eysins,
Switzerland). Viral nucleic acid was extracted from blood samples using Viral RNA mini
kit (Qiagen, Manchester, UK) and viral DNA levels (genome copies) were determined by
real time PCR.
4.2. Evaluation of Lesions and Detection of African Swine Fever Virus in Tissue Samples
During necropsies, macroscopic lesions were evaluated following a revised version of
previous protocols [37] which were adapted to include simplified pathological evaluation
criteria and agreed by veterinary pathologists from different institutions participating in
the ASF-Stop Cost Action Consortium (See Supplementary Material S1 (evaluation criteria
of macroscopic lesions and scoring system) and Supplementary Material S2 (macroscopic
lesions scoring sheet).
A huge range of tissue samples (Supplementary Material S3) were taken, fixed for
7 days in 10% buffered formalin solution and routinely processed for histopathological
and immunohistochemical studies. Histopathological lesions were evaluated following
pathological evaluation criteria in combination with a semi-quantitative scoring system as
follows: (0) no lesion; (1) minimal lesion; (2) mild lesion; (3) moderate lesion; (4) severe lesion
(Supplementary Material S3: histopathological evaluation criteria and scoring system).
Tissue sections were also used for immunohistochemical demonstration of ASFV by
a monoclonal antibody against the virus protein p30/CP204L (The Pirbright Institute,
Pirbright, UK). Briefly, sections were deparaffinised and rehydrated and endogenous per-
oxidase activity was quenched by incubation with 3% hydrogen peroxide in methanol for
15 min (min) at room temperature (RT). Then, samples were subjected to heat-induced
epitope retrieval by immersion in DAKO buffer (pH 9) at 100 ◦C for 10 min. After treatment,
sections were cooled at RT (20 min) and rinsed in TBST buffer wash (pH 7.2) for 5 min.
Nonspecific binding sites were blocked with normal serum block (5% normal goat, 5% nor-
mal swine, 5% normal chicken in TBST buffer) for 20 min. After the blocking step, sections
were incubated with a primary monoclonal antibody against virus protein p30/CP204L
(10 µg/mL in TBST buffer) for 1 h at RT. After primary incubation, sections were washed
with TBST buffer (2 × 5 min). EnVision (DAKO, Glostrup, Denmark) was utilized for
visualization (30 min. incubation at RT) and 3,3′-diaminobenzidine (DAB) 0.05% solution
in Mcllvaine’s phosphate citrate buffer containing hydrogen peroxide 0.001% was applied
for 10 min. as the chromogen. Then, samples were rinsed with distilled (1 × 5 min) and tap
water (1 × 5 min). Finally, sections were counterstained with Mayer’s haematoxylin, dehy-
drated and mounted. Tissue samples from infected and noninfected pigs were included
as test controls. In addition, specific primary antibody was replaced by (1) PBS and (2) a
subtype matching IgG to serve as two primary antibody-omit negative technique controls.
A detailed protocol including all steps and reagents used is provided (Supplementary
Material S4: ASFV detection by immunohistochemistry).
A semiquantitative assessment of cells immunolabeled for viral antigen (protein
p30/CP204L) was performed on different histological structures of organs which were
evaluated as follows: (0) no presence of immunolabeled cells; (1) occasional presence of
immunolabeled cells; (2) mild presence of immunolabeled cells; (3) moderate presence
of immunolabeled cells; (4) abundant presence of immunolabeled cells. Morphological
features, location and size were the criteria applied to identify the types of immunolabeled
cells (Supplementary Material S5: scoring of cells immunolabeled for viral antigen in
different histological structures; Supplementary Figure S1: examples for the assessment of
cells immunolabeled for viral antigen in different organs).
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4.3. Statistical Analysis
Macroscopic and histopathological scores along with the scores of cells immuno-
labeled for viral antigen were expressed as medians with 95% confidence interval (CI).
Differences among experimental groups were tested for statistical significance using one-
way ANOVA. All statistical analyses and data visualisation were performed with GraphPad
Prism Version 7.0 (GraphPad Software, La Jolla, CA, USA).
5. Conclusions
In this study, we made use of an intranasal infection model for ASFV where the dose
of infection influenced the outcome of clinical presentation, and where the correlation of
clinical scores with pathological lesions (both gross- and histopathology) was reviewed.
The study corroborates the moderate virulence of the Ken05/Tk1 isolate, as well as its
capacity to induce both acute and, occasionally, subacute forms of ASF when medium and
high doses were administered intranasally. The severity of vascular lesions induced by
high and medium doses was not associated with the amount of virus detected in tissues
and might be attributed to indirect mechanisms not evaluated in the present study. The
proposed evaluation protocols enable the simplification of the pathological evaluations
carried out in ASF studies and the set-up differences among animals and experimental
groups in a faster, more accurate and reliable way, also facilitating the standardized and
harmonized comparison of ASF lesions across studies.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/pathogens10060768/s1; File S1: evaluation criteria of macroscopic lesions and scoring system;
File S2: macroscopic lesions scoring sheet; File S3: histopathological evaluation criteria and scoring
system; File S4: ASFV detection by immunohistochemistry; File S5: scoring of cells immunolabeled
for viral antigen in different histological structures; Figure S1: examples for the assessment of cells
immunolabeled for viral antigen in different organs.
Author Contributions: Conceptualization, P.J.S.-C., A.N. (Alejandro Núñez), H.R.C.; methodology,
P.J.S.-C., T.F., D.H., H.R.C., S.M., R.R.M., R.S., L.K.D., A.N. (Aleksija Neimanis), E.W.-L., D.G.-W.,
A.N. (Alejandro Núñez), resources, H.R.C., A.N. (Alejandro Núñez); writing—original P.J.S.-C.;
writing—review and editing, P.J.S.-C., T.F., D.H., H.R.C., L.K.D., A.N. (Aleksija Neimanis), E.W.-L.,
D.G.-W., A.N. (Alejandro Núñez); funding acquisition, H.R.C., A.N. (Alejandro Núñez); All authors
have read and agreed to the published version of the manuscript.
Funding: The animal study was funded under an Innovate UK and Genus funded sub-contract from
the Roslin Institute and APHA (CSKN0019). This research was also financially supported by the
Department for Environment, Food and Rural Affairs (DEFRA), the Scottish Government and the
Welsh Government. The development and refinement of the scoring systems was supported by the
Swedish Environmental Protection Agency.
Institutional Review Board Statement: Studies were reviewed by the APHA animal welfare and
ethical review board and conducted in accordance with the UK Animals (Scientific Procedures) Act
1986 under project licence PF971B5E3.
Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Acknowledgments: The authors would like to thank Pathology and Animal Sciences Department
staff (APHA, New Haw, UK), especially to Stuart Ackroyd and Sarah Marsh, for their assistance and
contribution during histopathological and immunohistochemical studies, as well as Jane Edwards
and Virology Department staff (APHA, New Haw, UK) for advice and contributions to processing
of laboratory samples. We wish also thank Carmina Gallardo and colleagues (CISA-INIA, CSIC,
Valdeolmos, Spain) for provision of the Ken05/Tk1 isolate and advice, ASU staff (APHA, UK) for
their assistance during animal procedures and clinical monitoring and Linda Dixon’s group (The
Pirbright Institute, Pirbright, UK) for preparing and providing the antibodies against ASFV and
contributing to develop the immunohistochemical methods. We thank Simon Lillico and colleagues
Pathogens 2021, 10, 768 21 of 23
from the Roslin Institute for input into the design of the animal study. We also thank Falko Steinbach
for his critical review of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Alonso, C.; Borca, M.; Dixon, L.; Revilla, Y.; Rodriguez, F.; Escribano, J.M. Ictv Report Consortium. ICTV Virus Taxonomy Profile:
Asfarviridae. J. Gen. Virol. 2018, 99, 613–614. [CrossRef]
2. Wilkinson, P.J. African swine fever virus. In Virus Infections of Porcines; Pensaert, M.B., Ed.; Elsevier Science Publishers: Amsterdam,
The Netherlands, 1989; pp. 17–35.
3. Montgomery, R.E. On a form of swine fever occurring in British East Africa (Kenya Colony). J. Comp. Pathol. Ther. 1921, 34,
159–191. [CrossRef]
4. Linden, A.; Licoppe, A.; Volpe, R.; Paternostre, J.; Lesenfants, C.; Cassart, D.; Garigliany, M.; Tignon, M.; van den Berg, T.;
Desmecht, D.; et al. Summer 2018: African swine fever virus hits north-western Europe. Transbound. Emerg. Dis. 2019, 66, 54–55.
[CrossRef]
5. Sauter-Louis, C.; Forth, J.H.; Probst, C.; Staubach, C.; Hlinak, A.; Rudovsky, A.; Holland, D.; Schlieben, P.; Göldner, M.; Schatz, J.;
et al. Joining the club: First detection of African swine fever in wild boar in Germany. Transbound. Emerg. Dis. 2020. [CrossRef]
6. Ge, S.; Li, J.; Fan, X.; Liu, F.; Li, L.; Wang, Q.; Ren, W.; Bao, J.; Liu, C.; Wang, H.; et al. Molecular characterization of African swine
fever Virus, China. Transbound. Emerg. Dis. 2018, 24, 2131–2133. [CrossRef]
7. OIE, African swine fever (ASF) Report N◦ 64: 5–18 February 2021. Available online: https://www.oie.int/fileadmin/Home/
eng/Animal_Health_in_the_World/docs/pdf/Disease_cards/ASF/Report_64_Current_situation_of_ASF.pdf. (accessed on 18
February 2021).
8. Bastos, A.D.; Penrith, M.L.; Cruciere, C.; Edrich, J.L.; Hutchings, G.; Roger, F.; Couacy- Hymann, E.; Thomson, G.R. Genotyping
field strains of African swine fever virus by partial p72 gene characterisation. Arch. Virol. 2003, 148, 693–706. [CrossRef] [PubMed]
9. Achenbach, J.E.; Gallardo, C.; Nieto-Pelegrin, E.; Rivera-Arroyo, B.; Degefa-Negi, T.; Arias, M.; Jenberie, S.; Mulisa, D.D.; Gizaw,
D.; Gelaye, E.; et al. Identification of a new genotype of African swine fever virus in domestic pigs from Ethiopia. Transbound.
Emerg. Dis. 2017, 5, 1393–1404. [CrossRef] [PubMed]
10. Forth, J.H.; Forth, L.F.; King, J.; Groza, O.; Hübner, A.; Olesen, A.S.; Höper, D.; Dixon, L.K.; Netherton, C.L.; Rasmussen, T.B.; et al.
A Deep-Sequencing Workflow for the Fast and Efficient Generation of High-Quality African Swine Fever Virus Whole-Genome
Sequences. Viruses 2019, 11, 846. [CrossRef]
11. Sierra, M.A.; Bernabé, A.; Mozos, E.; Méndez, A.; Jover, A. Ultrastructure of the liver in pigs with experimental African swine
fever. Vet. Pathol. 1987, 24, 460–462. [CrossRef]
12. Sierra, M.A.; Carrasco, L.; Gómez-Villamandos, J.C.; Martín de las Muías, J.; Méndez, A.; Jover, A. Pulmonary intravascular
macrophages in pigs inoculated with African swine fever virus of differing virulence. J. Comp. Pathol. 1990, 102, 323–334.
[CrossRef]
13. Gómez-Villamandos, J.C.; Hervás, J.; Méndez, A.; Carrasco, L.; Villeda, C.J.; Wilkinson, P.J.; Sierra, M.A. Pathological changes of
renal interstitial capillaries in pigs inoculated with two different strains of African swine fever virus. J. Comp. Pathol. 1995, 112,
283–298. [CrossRef]
14. Rodríguez, F.; Fernández, A.; Martín de las Mulas, J.P.; Sierra, M.A.; Jover, A. African swine fever: Morphopathology of a viral
haemorrhagic disease. Vet. Rec. 1996, 139, 249–254. [CrossRef] [PubMed]
15. Salguero, F.J.; Ruiz-Villamor, E.; Bautista, M.J.; Sánchez-Cordón, P.J.; Carrasco, L.; Gómez-Villamandos, J.C. Changes in
macrophages in spleen and lymph nodes during acute African swine fever: Expression of cytokines. Vet. Immunol. Immunopathol.
2002, 90, 11–22. [CrossRef]
16. Boinas, F.S.; Hutchings, G.H.; Dixon, L.K.; Wilkinson, P.J. Characterization of pathogenic and non-pathogenic African swine
fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal. J. Gen. Virol. 2004, 85, 2177–2187. [CrossRef]
[PubMed]
17. Sánchez-Cordón, P.J.; Romero-Trevejo, J.L.; Pedrera, M.; Sánchez-Vizcaíno, J.M.; Bautista, M.J.; Gómez-Villamandos, J.C. Role of
hepatic macrophages during the viral haemorrhagic fever induced by African swine fever virus. Histol. Histopathol. 2008, 23,
683–691. [CrossRef]
18. De Carvalho Ferreira, H.C.; Weesendorp, E.; Elbers, A.R.W.; Bouma, A.; Quak, S.; Stegeman, J.A.; Loeffen, W.L.A. African swine
fever virus excretion patterns in persistently infected animals: A quantitative approach. Vet. Microbiol. 2012, 160, 327–340.
[CrossRef]
19. Howey, E.B.; O’Donnell, V.; de Carvalho Ferreira, H.C.; Borca, M.V.; Arzt, J. Pathogenesis of highly virulent African swine fever
virus in domestic pigs exposed via intraoropharyngeal, intranasopharyngeal, and intramuscular inoculation, and by direct
contact with infected pigs. Virus Res. 2013, 178, 328–339. [CrossRef]
20. Post, J.; Weesendorp, E.; Montoya, M.; Loeffen, W.L. Influence of age and dose of African swine fever virus infections on clinical
outcome and blood parameters in pigs. Viral Immunol. 2017, 30, 58–69. [CrossRef]
21. Gabriel, C.; Blome, S.; Malogolovkin, A.; Parilov, S.; Kolbasov, D.; Teifke, J.P.; Beer, M. Characterization of African swine fever
virus Caucasus isolate in European wild boars. Emerg. Infect. Dis. 2011, 17, 2342–2345. [CrossRef]
Pathogens 2021, 10, 768 22 of 23
22. Blome, S.; Gabriel, C.; Dietze, K.; Breithaupt, A.; Beer, M. High virulence of African swine fever virus Caucasus isolate in
European wild boars of all ages. Emerg. Infect. Dis. 2012, 18, 708. [CrossRef]
23. Guinat, C.; Reis, A.L.; Netherton, C.L.; Goatley, L.; Pfeier, D.U.; Dixon, L. Dynamics of African swine fever virus shedding and
excretion in domestic pigs infected by intramuscular inoculation and contact transmission. Vet. Res. 2014, 45, 93. [CrossRef]
24. Pietschmann, J.; Guinat, C.; Beer, M.; Pronin, V.; Tauscher, K.; Petrov, A.; Keil, G.; Blome, S. Course and transmission characteristics
of oral low-dose infection of domestic pigs and European wild boar with a Caucasian African swine fever virus isolate. Arch.
Virol. 2015, 160, 1657–1667. [CrossRef]
25. Gallardo, C.; Nurmoja, I.; Soler, A.; Delicado, V.; Simón, A.; Martin, E.; Perez, C.; Nieto, R.; Arias, M. Evolution in Europe of
African Swine Fever Genotype II Viruses from Highly to Moderately Virulent. Vet. Microbiol. 2018, 219, 70–79. [CrossRef]
26. Gallardo, C.; Soler, A.; Rodze, I.; Nieto, R.; Cano-Gómez, C.; Fernandez-Pinero, J.; Arias, M. Attenuated and non-haemadsorbing
(non-HAD) genotype II African swine fever virus (ASFV) isolated in Europe, Latvia 2017. Transbound. Emerg. Dis. 2019, 66,
1399–1404. [CrossRef] [PubMed]
27. Global African Swine Fever Research Alliance (GARA) Gap Analysis Report. 2018; pp. 25–28. Available online:
https://www.ars.usda.gov/ARSUserFiles/np103/SymposiumWorkshopsMeetings/GARA%20Gap%20Analysis%20Report%
202018%2011-11-18.pdf (accessed on 15 November 2018).
28. Gallardo, C.; Fernández-Pinero, J.; Pelayo, V.; Gazaev, I.; Markowska-Daniel, I.; Pridotkas, G.; Nieto, R.; Fernández-Pacheco, P.;
Bokhan, S.; Nevolko, O.; et al. Genetic variation among African swine fever genotype II viruses, eastern and central Europe.
Emerg. Infect. Dis. 2014, 20, 1544–1547. [CrossRef] [PubMed]
29. Luka, P.D.; Achenbach, J.E.; Mwiine, F.N.; Lamien, C.E.; Shamaki, D.; Unger, H.; Erume, J. Genetic characterization of circulating
African swine fever viruses in Nigeria (2007–2015). Transbound. Emerg. Dis. 2017, 64, 1598–1609. [CrossRef] [PubMed]
30. Quembo, C.J.; Jori, F.; Vosloo, W.; Heath, L. Genetic characterization of African swine fever virus isolates from soft ticks at the
wildlife/domestic interface in Mozambique and identification of a novel genotype. Transbound. Emerg. Dis. 2018, 65, 420–431.
[CrossRef]
31. Tignon, M.; Gallardo, C.; Iscaro, C.; Hutet, E.; Van der Stede, Y.; Kolbasov, D.; De Mia, G.M.; Le Potier, M.F.; Bishop, R.P.; Arias,
M.; et al. Development and inter-laboratory validation study of an improved new real-time PCR assay with internal control for
detection and laboratory diagnosis of African swine fever virus. J. Virol. Methods. 2011, 178, 161–170. [CrossRef] [PubMed]
32. Sánchez-Vizcaíno, J.M.; Mur, L.; Gomez-Villamandos, J.C.; Carrasco, L. An update on the epidemiology and pathology of African
swine fever. J. Comp. Pathol. 2015, 152, 9–21. [CrossRef]
33. Sánchez-Cordón, P.J.; Chapman, D.; Jabbar, T.; Reis, A.L.; Goatley, L.; Netherton, C.L.; Taylor, G.; Montoya, M.; Dixon, L.
Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate
OURT88/3. Antivir. Res. 2017, 138, 1–8. [CrossRef]
34. Sánchez-Vizcaíno, J.M.; Mur, L.; Martinez-Lopez, B. African swine fever: An epidemiological update. Transbound. Emerg. Dis.
2012, 59, 27–35. [CrossRef] [PubMed]
35. McCleary, S.; Strong, R.; McCarthy, R.R.; Edwards, J.C.; Howes, E.L.; Stevens, L.M.; Sánchez-Cordón, P.J.; Núñez, A.; Watson, S.;
Mileham, A.J.; et al. Substitution of warthog NF-κB motifs into RELA of domestic pigs is not sufficient to confer resilience to
African swine fever virus. Sci. Rep. 2020. accepted. [CrossRef] [PubMed]
36. Gallardo, C.; Okoth, E.; Pelayo, V.; Anchuelo, R.; Martín, E.; Simón, A.; Llorente, A.; Nieto, R.; Soler, A.; Martín, R.; et al. African
swine fever viruses with two different genotypes, both of which occur in domestic pigs, are associated with ticks and adult
warthogs, respectively, at a single geographical site. J. Gen. Virol. 2011, 92, 432–444. [CrossRef] [PubMed]
37. Galindo-Cardiel, I.; Ballester, M.; Solanes, D.; Nofrarías, M.; López-Soria, S.; Argilaguet, J.M.; Lacasta, A.; Accensi, F.; Rodríguez,
F.; Segalés, J. Standardization of pathological investigations in the framework of experimental ASFV infections. Virus Res. 2013,
173, 180–190. [CrossRef]
38. Gomez-Villamandos, J.C.; Bautista, M.J.; Sanchez-Cordon, P.J.; Carrasco, L. Pathology of African swine fever: The role of
monocyte–macrophage. Virus Res. 2013, 173, 140–149. [CrossRef] [PubMed]
39. Gómez-Villamandos, J.C.; Hervás, J.; Méndez, A.; Carrasco, L.; Martín de las Mulas, J.; Villeda, C.J.; Wilkinson, P.J.; Sierra, M.A.
Experimental African swine fever: Apoptosis of lymphocytes and virus replication in other cells. J. Gen. Virol. 1995, 76, 2399–2405.
[CrossRef]
40. Gómez-Villamandos, J.C.; Bautista, M.J.; Carrasco, L.; Chacón-Manrique de Lara, F.; Hervás, J.; Wilkinson, P.J.; Sierra, M.A.
Thrombocytopenia associated with apoptotic megakaryocytes in a viral haemorrhagic syndrome induced by a moderately
virulent strain of African swine fever virus. J. Comp. Pathol. 1998, 118, 1–13. [CrossRef]
41. Romero-Palomo, F.; Sánchez-Cordón, P.J.; Pedrera, M.; Risalde, M.A.; Molina, V.; Sánchez-Vizcaíno, J.M.; Gómez-Villamandos,
J.C. Histopathologic study and viral antigen distribution in tissues of pigs inoculated with isolate Ken05/Tk1 of African swine
fever virus. Proc. XI Natl. Congr. Virol. Granada Spain 2011, 14, 240–241.
42. Zaman, M.; Chandrudu, S.; Toth, I. Strategies for intranasal delivery of vaccines. Drug Deliv. Transl. Res. 2013, 3, 100–109.
[CrossRef]
43. Heuschele, W.P. Studies on the pathogenesis of African swine fever. I. Quantitative studies on the sequential development of
virus in pig tissues. Arch. Gesamte. Virusforsch. 1967, 21, 349–356. [CrossRef]
44. Plowright, W.; Parker, J.; Staple, R.F. The growth of a virulent strain of African swine fever virus in domestic pigs. J. Hyg. 1968, 66,
117–134. [CrossRef]
Pathogens 2021, 10, 768 23 of 23
45. Misinzo, G.; Kwavi, D.E.; Sikombe, C.D.; Makange, M.; Peter, E.; Muhairwa, A.P.; Madege, M.J. Molecular characterization of
African swine fever virus from domestic pigs in northern Tanzania during an outbreak in 2013. Trop. Anim. Health Prod. 2014, 46,
1199–1207. [CrossRef] [PubMed]
46. Bishop, R.P.; Fleischauer, C.; de Villiers, E.P.; Okoth, E.A.; Arias, M.; Gallardo, C.; Upton, C. Comparative analysis of the complete
genome sequences of Kenyan African swine fever virus isolates within p72 genotypes IX and X. Virus Genes 2015, 50, 303–309.
[CrossRef] [PubMed]
47. Gallardo, C.; Nieto, R.; Mur, L.; Soler, A.; Pelayo, V.; Bishop, R.; Sánchez-Cordón, P.J.; Martins, C.; Sánchez-Vizcaíno, J.M.; Arias,
M. African swine fever (ASF) in Africa. The role of the African indigenous pigs in the transmission of the disease. In Proceedings
of the 6th Annual Meeting Epizone, Brighton, UK, 12–14 June 2012; p. 15.
48. Gallardo, C.; Soler, A.; Nieto, R.; Carrascosa, A.L.; De Mia, G.M.; Bishop, R.P.; Martins, C.; Fasina, F.O.; Couacy-Hymman, E.;
Heath, L.; et al. Comparative evaluation of novel African swine fever virus (ASF) antibody detection techniques derived from
specific ASF viral genotypes with the OIE internationally prescribed serological tests. Vet. Microbiol. 2013, 162, 32–43. [CrossRef]
49. Okoth, E.; Gallardo, C.; Macharia, J.M.; Omore, A.; Pelayo, V.; Bulimo, D.W.; Arias, M.; Kitala, P.; Baboon, K.; Lekolol, I.; et al.
Comparison of African swine fever virus prevalence and risk in two contrasting pig-farming systems in South-west and Central
Kenya. Prev. Vet. Med. 2013, 110, 198–205. [CrossRef]
50. Abworo, E.O.; Onzere, C.; Oluoch Amimo, J.; Riitho, V.; Mwangi, W.; Davies, J.; Blome, S.; Bishop, R.P. Detection of African swine
fever virus in the tissues of asymptomatic pigs in smallholder farming systems along the Kenya-Uganda border: Implications for
transmission in endemic areas and ASF surveillance in East Africa. J. Gen. Virol. 2017, 98, 1806–1814. [CrossRef]
51. Costard, S.; Mur, L.; Lubroth, J.; Sanchez-Vizcaino, J.M.; Pfeiffer, D.U. Epidemiology of African swine fever virus. Virus Res. 2013,
173, 191–197. [CrossRef]
52. Gallardo, C.; Soler, A.; Nieto, R.; Sánchez, M.A.; Martins, C.; Pelayo, V.; Carrascosa, A.; Revilla, Y.; Simón, A.; Briones, V.; et al.
Experimental Transmission of African swine fever low virulent isolate NH/P68 by surviving pigs. Transbound. Emerg. Dis. 2015,
62, 612–622. [CrossRef] [PubMed]
53. Ståhl, K.; Sternberg-Lewerin, S.; Blome, S.; Viltrop, A.; Penrith, M.L.; Chenais, E. Lack of evidence for long term carriers of African
swine fever virus—A systematic review. Virus Res. 2019, 272, 197725. [CrossRef]
54. Oura, C.A.; Powell, P.P.; Parkhouse, R.M. African swine fever: A disease characterized by apoptosis. J. Gen. Virol. 1998, 79,
1427–1438. [CrossRef]
55. Ramiro-Ibáñez, F.; Escribano, J.M.; Alonso, C. Application of a monoclonal antibody recognizing protein p30 to detect African
swine fever virus-infected cells in peripheral blood. J. Virol. Methods. 1995, 55, 339–345. [CrossRef]
56. Sánchez-Torres, C.; Gómez-Puertas, P.; Gómez del Moral, M.; Alonso, F.; Escribano, J.M.; Ezquerra, A.; Domínguez, J. Expression
of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection. Arch Virol. 2003,
148, 2307–2323. [CrossRef] [PubMed]
57. Lithgow, P.; Takamatsu, H.; Werling, D.; Dixon, L.; Chapman, D. Correlation of cell surface marker expression with African swine
fever virus infection. Vet. Microbiol. 2014, 31, 413–419. [CrossRef] [PubMed]
58. Alcami, A.; Carrascosa, A.L.; Viñuela, E. Interaction of African swine fever virus with macrophages. Virus Res. 1990, 17, 93–104.
[CrossRef]
